warning icon

COVID-19 DEW Report, powered by Reformulary®Read more

@var craft \craft\web\twig\variables\CraftVariable Header

UK to run final stage trials of Janssen COVID-19 vaccine

Johnson & Johnson subsidiary Janssen is moving ahead with a late-stage clinical trial of its COVID-19 vaccine candidate, beginning with recruiting 6,000 participants in the United Kingdom with plans to eventually enrol 30,000 people in six countries worldwide. One source of optimism is that the vaccine delivers its protection through the same spike protein mechanism that Pfizer’s candidate, recently found to have 90% effectiveness in preliminary data, uses. Trial organizers hope to recruit a participant pool that reflects groups hit hardest by the disease, including the elderly and minority groups.

Published: November 16, 2020

CTV News

Read Article